Vanberra Signal

BioSensors

Curated by Signal

Non-invasive wearable device using electromagnetic impedance technologies

Overview

BioSensors Technology is an early stage company develops non-invasive continuous glucose measurement technology is based on the applications of electromagnetic impedance spectroscopy (EIS) and electromagnetic impedance tomography (EIT). The product is proposed to be wearable (watch) which gives glucose readings. The sensor system is in form of a thin disposable patch placed on the lower back or abdominal region. The applications of the device can be extended to measure uric acid, lactic acid, and hydration levels. The company is 60% owned by TransTech Systems.

Key facts

Founded
2009

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Point of care diagnostic test for preeclampsia

    Life Sciences TechnologyGuilford, United States
  • Provider of precision gene editing solutions throug synthetic biology and AI algorithms for advancing genomic medicine

    Life Sciences TechnologyBoston, United States
  • Maternal and fetal monitoring sensors

    Life Sciences TechnologyNewberry, United States

About BioSensors

What does BioSensors do?

BioSensors Technology is an early stage company develops non-invasive continuous glucose measurement technology is based on the applications of electromagnetic impedance spectroscopy (EIS) and electromagnetic impedance tomography (EIT).

Where is BioSensors headquartered?

BioSensors is headquartered in Schenectady, United States.

When was BioSensors founded?

BioSensors was founded in 2009.

Which sector is BioSensors in?

BioSensors operates in Life Sciences Technology.

Who are BioSensors's competitors?

Companies similar to BioSensors include GestVision, Neoclease, and OBMedical Company.